- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06329375
Food Insecurity Reduction & Strategy Team (FIRST)
This study seeks to address the multifaceted challenges posed by food disparities and their negative consequences on health outcomes, via a comprehensive community health intervention program. Study objectives include:
- To describe the social-demographic and clinical factors associated with food insecurity in the hospitalized diabetic population.
- To design, implement and evaluate a nutrition program targeting the hospitalized diabetic population. The investigators will prospectively randomize the target population into either a nutrition program (Intervention), or state-of-art standard of care (SOC) in a 4:1 ratio. Participants in the intervention group will be provided the following two resources in addition to SOC: 1) Enhanced access to nutritious food (twice daily meal delivery up to 90 days post-discharge) 2) Education at discharge and continuing outreach to enhance knowledge for better diet and food options.
- To enhance community engagement and develop a systematic implementation plan for long-term roll-out of the nutrition program.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Christine Santiago, MD
- Phone Number: (650) 725-5071
- Email: csantia2@stanford.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of Type 1 or Type 2 Diabetes Mellitus
- Admitted to Stanford Healthcare inpatient unit
- Residence in California at time of enrollment
- Positive Screening for Food Insecurity
- On a Healthcare Plan covered by Mom's Meals.
Exclusion Criteria:
- Plans to be discharged to a skilled nursing facility.
- Patients who prefer a language for which a short-form consent is not available.
- No Home Address
- Pregnant Participants.
- No access to refrigerator.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: SoC group
Standard of care (SOC)
|
|
Experimental: Nutrition program (Intervention)
Patients in the intervention group will be provided the following two resources in addition to SOC:
|
Nutrition program with twice daily meal delivery up to 90 days post-discharge and food and diet education at discharge.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Food insecurity at 30-days post initial discharge
Time Frame: 30 days from discharge
|
Primary outcome is whether the participant had food insecurity in the past 30 days, measured at 30-days post initial discharge by the Food Insecurity Reduction and Strategy Team (FIRST) Survey Instrument questionnaire.
|
30 days from discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Food insecurity at 60- and 90- days post post initial discharge
Time Frame: 60-, and 90- days from discharge
|
The secondary outcome is whether the participant had food insecurity in the past 30 days, measured at 60-days and 90-days post initial discharge by the Food Insecurity Reduction and Strategy Team (FIRST) Survey Instrument questionnaire:
|
60-, and 90- days from discharge
|
Measures of diabetes stress
Time Frame: 30-,60-, and 90- days from discharge
|
Feeling overwhelmed by the demands of living with Diabetes measured using ordinal scale with range 1-6.
|
30-,60-, and 90- days from discharge
|
Measures of hypoglycemia
Time Frame: 30-,60-, and 90- days from discharge
|
Whether ever having a low blood sugar (low glucose or hypoglycemic) reaction in the past 4 weeks and number of times having a low blood sugar (low glucose or hypoglycemic) reaction in the past 4 weeks.
(ordinal scale: 0, 1-3, 4-7, 8+)
|
30-,60-, and 90- days from discharge
|
Measures of medication adherence
Time Frame: 30-,60-, and 90- days from discharge
|
Proportion of participants who missed their recommended diabetes medication in the past 7 days at least once and the mean number of days that the medication was missed in the past 7 days, measured using measured by participant self-report during survey response collection at 30-,60-, and 90-days post-discharge.
|
30-,60-, and 90- days from discharge
|
Hospitalization
Time Frame: 30-,60-, and 90- days from discharge
|
Proportion of participants having overnight hospitalizations in the past 30 days and mean number of nights with overnight hospitalizations in the past 30 days measured by participant self-report during survey response collection at 30-,60-, and 90-days post-discharge.
|
30-,60-, and 90- days from discharge
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Neera Ahuja, MD, Stanford University
- Principal Investigator: Christine Santiago, MD, Stanford University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 72967
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationRecruitingType 2 Diabetes Mellitus With ComplicationIndia
Clinical Trials on Nutrition program
-
Massachusetts General HospitalRecruitingPancreatic Ductal AdenocarcinomaUnited States
-
Florida State UniversityRecruitingAlzheimer Disease | Mild Cognitive ImpairmentUnited States
-
Tufts UniversityCompletedSedentary | Functionally LimitedUnited States
-
Stanford UniversityRecruiting
-
Taipei Medical University WanFang HospitalAsia UniversityNot yet recruitingRadiotherapy Side Effect | Nutrition Related CancerTaiwan
-
Istanbul University - Cerrahpasa (IUC)Completed
-
Universidad de SonoraCompletedChildhood ObesityMexico
-
Universidad de SonoraUniversidad de León; Centro de Investigación en Alimentación y Desarrollo A.C. and other collaboratorsRecruiting
-
The Hong Kong Polytechnic UniversityChinese University of Hong KongUnknownBreastfeeding | Infant Development
-
National Taiwan University HospitalNational Science Council, TaiwanUnknown